drugset / Trial / NCT05664659
Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section
RandomizedParallel-groupDouble-blindPrevention
Summary
The aim of this clinical trial is to test if carbetocin is as effective as oxytocin plus misoprostol in decreasing intraoperative blood loss in women undergoing planned cesarean section. The main question it aims to answer is: \* Is carbetocin as effective as oxytocin plus misoprostol in decreasing intraoperative blood loss in women undergoing planned cesarean section? Researchers will compare 2 groups: * women receiving Oxytocin plus Misoprostol; * women receiving Carbetocin as regards: * estimated blood loss
Timeline
- Start
- 2022-12-20
- Primary completion
- 2023-04-30
- Completion
- 2023-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbetocin | Peptide | 100 ug | Intravenous |
| Comparator | Misoprostol | Other / unclassified | 600 ug | Rectal |
| Comparator | Oxytocin | Peptide | 20 iu | Intravenous |
Indications
No indication recorded.